Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Trivedi Science™ Increases the Medicinal and Cancer Fighting Properties of Withania Somnifera / Ashwagandha
  • USA - English


News provided by

Trivedi Global Inc.

Jun 21, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Withania Somnifera: A. Control, B. Biofield Treatment
Withania Somnifera: A. Control, B. Biofield Treatment

Las Vegas, Nevada (PRWEB) June 21, 2015 -- During their complimentary online live broadcast to the public in June 2015, Trivedi Master Wellness™ shared their latest science breakthrough on the impact of consciousness/biofield energy on material phenomena, including the medicinal properties of plants. Mahendra Kumar Trivedi’s first Master Student Gopal Nayak received his second science publication, which was accepted by the U.S. based peer-reviewed science journal called the “Journal of Environment & Health Sciences” by Ommega Publishers. The research paper is titled “Effect of a Biofield Treatment on Plant Growth and Adaptation” and is now accessible to the public. The publication shows that the biofield treatment administered by Gopal Nayak was able to impact the adaptive response of the plant Withania somnifera, otherwise known as ashwagandha, Indian ginseng, poison gooseberry, or winter cherry.

This plant has highly potent medicinal properties that have been used to treat neurodegenerative disorders, cancer and stress. It is an herb that has been used for over 3,000 years in India’s ancient Ayurvedic modality of treatment and has recently gained a lot of hype and popularity in western medicine amongst doctors and health practitioners alike.

Gopal Nayak’s biofield energy transmission was applied to a group of Withania somnifera plants, while another group was left untreated to serve as a control group. The studies were performed both in vivo and in vitro and were assessed in terms of phenotypic and physiological parameters, such as germination, number of shoots per plant, length of the shoots, glutathione levels, quantity of chlorophyll a and b content, anticancer activity in HepG2 cells, DNA polymorphism and secondary metabolites (i.e. withaferin A and withanolide D). The results showed that all of the treated plants in vitro had an earlier germination and matured much more quickly, which is indicative of higher levels of vitality in the plant life. There were very obvious morphological differences in the treated plants versus the control plants, such as thicker and shorter roots and greater quantity, as well as a greater increase in plant immunity and levels of active constituents.

The treated plants’ total chlorophyll levels, including chlorophyll a and b, showed a consistent and significant increase both in vivo and in vitro. In comparison to the control group, concentrations of chlorophyll b increased by 660% in vivo, and total chlorophyll levels increased up to 428% when compared to the control group. The biofield treatment was able to increase the Glutathione (GSH) levels up to 20.9% more than the control group. Results from HPLC testing revealed an increase of Withania somnifera metabolites, including an increase by 48% in withaferin A and a 21% increase in withanolide D. On a final and promising note, extracts taken from the treated plants showed the highest anticancer activity in comparison to the control group, assessed using MTT assay in HepG2 cells. The full publication is available here: http://www.ommegaonline.com//form/issues/effect-of-a-biofield-treatment.php

Based on these results, the treated plants showed enhanced and more potent medicinal properties than the control group, showing that the Biofield Treatment is capable of increasing the medicinal potency, yield and overall efficacy of Withania somnifera, which can be an invaluable source of treatment for neurodegenerative disorders, stress and cancer.

Though these results deem themselves extraordinary, this is not Trivedi Science™’s first groundbreaking research on the impact of Biofield Energy on material phenomena. Mahendra Kumar Trivedi, founder of Trivedi Science™, has been using The Trivedi Effect® (otherwise known as Biofield Treatment) in many different fields of Life Sciences and Materials Sciences, accumulating several thousands of independent scientific studies. These science experiments have lead to a substantial amount of publications in genetics, cancer, microbiology, biotechnology, materials science and agriculture. Gopal Nayak is one of Mahendra Trivedi’s first Master Students who also has the ability to administer Biofield Energy Treatments and replicate The Trivedi Effect®. Mr. Trivedi has created two more Masters since then: Trivedi Masters™ Alice Branton and Dahryn Trivedi. All publications and further details of the science experiments are available at: http://www.trivediscience.com

Currently, Mr. Trivedi is pursuing further science exploration in collaboration with U.S. FDA approved CRO’s to test The Trivedi Effect®’s impact on stem cells, antibiotics, nutraceuticals, pharmaceuticals and biopharmaceuticals in order to create new products on this planet that will have greater potency, efficacy, solubility, bioavailability, drug delivery methods, less toxicity, and will ultimately provide our current health care system with new products and methods to effectively combat serious medical concerns like drug-resistant bacteria, inflammation, stress and cancer.

Alice Branton, CEO, Trivedi Global Inc., https://www.trivedimasterwellness.com/, +1 (706) 814-1140, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.